Organization

Morioka, Japan

2 abstracts

Abstract
Phase II study of combination of radiotherapy with pembrolizumab plus chemotherapy in patients with previously untreated metastatic non-small cell lung cancer: North Japan Lung Cancer Study Group 1902.
Org: Omagari Kosei Medical Center, Daisen, Japan, Sendai, Japan, Hirosaki University Graduate School of Medicine, Hirosaki, Japan,
Abstract
Induction and concomitant chemoradiotherapy (CCRT) using modified TPF (docetaxel, cisplatin and 5-FU) for the patients with stage IVB advanced head and neck cancer.
Org: Iwate Medical University, Morioka, Japan, Japan Association for Development of Community Medicine, Yahaba,